Our lead development product
Beyond Iron+
Iron, approached through nutrient peptide delivery. Beyond Iron+ is being developed with phosvitin-derived phosphopeptides, with human validation as the next step.
Development · Not currently for sale
A formulation. A research programme.
The goal is to evaluate iron delivery alongside tolerability and adherence—not to assume performance from a label or a cell experiment. Product-specific human efficacy and digestive tolerability have not been established here.
No ordering, pricing or subscription plans are offered at this stage. Final formulation, directions and any market availability will depend on development, evidence and applicable requirements.
The technology inside
Phosphopeptides, not intact phosvitin.
Processed phosphopeptides are distinct from the whole egg-yolk protein. Laboratory iron-uptake findings provide a starting rationale, not a guarantee of absorption or human outcomes. Ecovatec supplies foundational ingredient science and processing/manufacturing know-how; Beyond develops the commercial formulation and brand.
Iron in everyday life
Different lives. Changing needs.
Explore iron’s role through monthly cycles, pregnancy and later life—and why reference intakes and individual care are different questions.
Women + Iron →Beyond Iron+ · Human study
Now comes the human part.
We are initiating the planning of a human study to investigate iron uptake, ferritin response, tolerability and adherence, according to the final protocol. Ethics approval and study authorization are not yet confirmed.
Interest only. Not recruitment or study enrollment.